Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1987-03-26
1990-03-06
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424633, 424639, 424647, 424653, 424655, 424689, 600 3, A61K 4300, A61N 512
Patent
active
049064509
ABSTRACT:
The radionuclide Tin, Sn-121 in a carrier hydroxide aggregate is disclosed for the treatment of arthritis and, in particular, rheumatoid arthritis of the hands, the interphalangeal joints of the fingers and the metacarpal joints of the hand.
The radioactive compound disclosed preferably has a particle size of <90 microns. The beta energy emission associated with Tin, Sn-121 has an energy of 0.38 meV. There are no gamma photons emited during the decay of Tin, Sn-121 to stable Antimony Sb-121. The half life of Tin, Sn-121 is 27.06 hours.
The method of preparation of the compound is disclosed along with the method of administration to the patient in need thereof.
REFERENCES:
patent: 4511551 (1985-04-01), Cardarelli et al.
patent: 4533541 (1985-08-01), Srivastava et al.
Erdar et al. "J. Inorg. Nucl. Chem.", 1968, 30(8) pp. 1985-1993 [Chemical Abstracts vol. 68, 1968.]
Sledge et al, "Expermental Radiation", Arthritis and Rheumatism, vol. 20, No. 7, Sep.-Oct. 1977, 1334-1342.
Bordoni Maurice E.
Lieberman Ephraim
Thornton Alfred K.
Bloom Leonard
Maples John S.
LandOfFree
Treatment of arthritis, including rheumatoid arthritis, with the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of arthritis, including rheumatoid arthritis, with the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of arthritis, including rheumatoid arthritis, with the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-46407